Drug discovery is a high-cost, high-risk endeavor that is under growing pressure from a market increasingly defined by first-mover advantage. Since the 1950s, the cost of developing new pharmaceuticals has roughly doubled every nine years—a phenomenon known as Eroom’s Law. Today, bringing a new drug to market takes an average of 10-15 years and costs…
Drug discovery is a high-cost, high-risk endeavor that is under growing pressure from a market increasingly defined by first-mover advantage. Since the 1950s, the cost of developing new pharmaceuticals has roughly doubled every nine years—a phenomenon known as Eroom’s Law. Today, bringing a new drug to market takes an average of 10-15 years and costs…
<iframe src="https://statesidedaily.com/embed/cluster/53b22fb551e76c056bd6dbb7b4f49d8dda1a9744" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Closing the data loop in AI-driven drug discovery"></iframe>